[ Price : $8.95]
FDA approves an expanded indication for Sanofis Tzield (teplizumab), allowing its use in children as young as one year old to dela...[ Price : $8.95]
Researchers describe FDA and congressional actions that will improve the ability of the new plausible mechanism pathway to lead to...[ Price : $8.95]
Gilead calls on FDA to rescind its decision to file a Cipla 505(b)(2) NDA for an apparent duplicate of Gileads Descovy.[ Price : $8.95]
FDA issues a Warning Letter to New Life Pharma citing serious manufacturing and regulatory violations tied to the companys product...[ Price : $8.95]
FDA extends by three months its review of a Sanofi BLA for a subcutaneous formulation of Sarclisa (isatuximab-irfc) for use in com...[ Price : $8.95]
FDA warns the University of California at San Francisco radiopharmaceutical facility about CGMP violations in its production of fi...[ Price : $8.95]
FDA warns Par USA/Endo USA about CGMP violations in its manufacturing of finished drugs.[ Price : $8.95]
FDA warns Chinas Xiamen Kang Zhongyuan Biotechnology Co. about producing drugs in insanitary conditions and making misleading or d...